CA1219207A - Process of radioimaging the myocardium of mammals utilizing radiolabeled lipophilic cations - Google Patents

Process of radioimaging the myocardium of mammals utilizing radiolabeled lipophilic cations

Info

Publication number
CA1219207A
CA1219207A CA000438933A CA438933A CA1219207A CA 1219207 A CA1219207 A CA 1219207A CA 000438933 A CA000438933 A CA 000438933A CA 438933 A CA438933 A CA 438933A CA 1219207 A CA1219207 A CA 1219207A
Authority
CA
Canada
Prior art keywords
halide
bromide
myocardium
quaternary
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000438933A
Other languages
English (en)
French (fr)
Inventor
David V. Woo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hahnemann University
Original Assignee
Hahnemann University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hahnemann University filed Critical Hahnemann University
Application granted granted Critical
Publication of CA1219207A publication Critical patent/CA1219207A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA000438933A 1982-10-13 1983-10-13 Process of radioimaging the myocardium of mammals utilizing radiolabeled lipophilic cations Expired CA1219207A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/433,871 US4446123A (en) 1982-10-13 1982-10-13 Process of radioimaging the myocardium of mammals utilizing radiolabeled lipophilic cations
US433,871 1982-10-13

Publications (1)

Publication Number Publication Date
CA1219207A true CA1219207A (en) 1987-03-17

Family

ID=23721862

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000438933A Expired CA1219207A (en) 1982-10-13 1983-10-13 Process of radioimaging the myocardium of mammals utilizing radiolabeled lipophilic cations

Country Status (10)

Country Link
US (1) US4446123A (enExample)
JP (1) JPS59139326A (enExample)
BE (1) BE897968A (enExample)
CA (1) CA1219207A (enExample)
DE (1) DE3336748A1 (enExample)
FR (1) FR2534576B1 (enExample)
GB (1) GB2128191B (enExample)
IT (1) IT1205396B (enExample)
LU (1) LU85042A1 (enExample)
NL (1) NL8303481A (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001271248A1 (en) * 2000-04-28 2001-11-12 Duke University 18f-labeled choline analogs
US6548042B2 (en) * 2000-08-07 2003-04-15 Arstad Erik Bis-phosphonate compounds
TWI266634B (en) * 2002-02-06 2006-11-21 Univ Johns Hopkins Non-invasive diagnostic imaging technology for mitochondria dysfunction using radiolabeled lipophilic salts
AU2011203177B2 (en) * 2004-02-24 2012-04-26 The General Hospital Corporation Catalytic radiofluorination
US9017724B2 (en) * 2004-02-24 2015-04-28 The General Hospital Corporation Catalytic radiofluorination
US8257680B1 (en) 2004-02-24 2012-09-04 The General Hospital Corporation Catalytic radiofluorination
EP2388017B1 (en) * 2004-02-24 2014-12-24 The General Hospital Corporation Catalytic radiofluorination
US8388936B2 (en) * 2008-02-22 2013-03-05 Mcw Research Foundation, Inc. In vivo mitochondrial labeling using positively-charged nitroxide enhanced and gadolinium chelate enhanced magnetic resonance imaging
MX375108B (es) 2008-03-21 2025-03-06 Massachusetts Gen Hospital Compuestos y composiciones para la deteccion y el tratamiento de la enfermedad de alzheimer y trastornos relacionados.
US9205156B2 (en) * 2010-05-27 2015-12-08 Hadasit Medical Research Services & Development Limited Molecular imaging agents
JP6285164B2 (ja) * 2013-12-05 2018-02-28 デクセリアルズ株式会社 化合物、熱硬化性樹脂組成物、及び熱硬化性シート

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107283A (en) * 1976-07-19 1978-08-15 New England Nuclear Corporation Tracer for circulation determinations
JPS5572640A (en) * 1978-11-27 1980-05-31 Automob Antipollut & Saf Res Center Air-fuel ratio control device
DE2965469D1 (en) * 1978-11-29 1983-07-07 Hoffmann La Roche Radioiodine containing amines, their preparation and their use as brain imaging agents
US4360511A (en) * 1978-11-29 1982-11-23 Medi-Physics, Inc. Amines useful as brain imaging agents
NL7900964A (nl) * 1979-02-07 1980-08-11 Byk Mallinckrodt Cil Bv Nieuwe radioactief gemerkte aminen, werkwijze ter bereiding van de nieuwe verbindingen, alsmede diagnostische preparaten op basis van de nieuwe verbindingen.
US4387087A (en) * 1980-04-18 1983-06-07 Research Corporation Cationic lipophilic complexes of 99m Tc and their use for myocardial and hepatobiliary imaging

Also Published As

Publication number Publication date
LU85042A1 (de) 1984-04-02
IT1205396B (it) 1989-03-15
GB2128191B (en) 1986-05-08
FR2534576A1 (fr) 1984-04-20
BE897968A (nl) 1984-01-30
JPS6217974B2 (enExample) 1987-04-21
GB2128191A (en) 1984-04-26
IT8368048A0 (it) 1983-10-12
US4446123A (en) 1984-05-01
DE3336748A1 (de) 1984-07-05
FR2534576B1 (fr) 1986-09-19
GB8327249D0 (en) 1983-11-16
JPS59139326A (ja) 1984-08-10
NL8303481A (nl) 1984-05-01

Similar Documents

Publication Publication Date Title
EP0038756B1 (en) Cationic lipophilic complexes of 99m tc useful for myocardial and hepatobiliary imaging
Kung et al. Synthesis and biodistribution of neutral lipid-soluble Tc-99m complexes that cross the blood-brain barrier
CA1219207A (en) Process of radioimaging the myocardium of mammals utilizing radiolabeled lipophilic cations
JPS6069090A (ja) テクネチウム−９９ｍのアルキレンアミンオキシムとの錯体
US4795626A (en) 99m Tc.sup.(III) myocardial imaging agents which are non-reducable in vivo
GB2064512A (en) Radiopharmaceuticals for localisation in target tissues exhibiting a regional ph shift relative to surrounding tissues
Motaleb et al. Synthesis and biological evaluation of 125 I-nebivolol as a potential cardioselective agent for imaging β 1-adrenoceptors
HK98097A (en) Ligands and cationic complexes thereof with technetium-99m
AU633597B2 (en) 99m tc(iii) myocardial imaging agents that are effective in humans
US4489054A (en) Cationic lipophilic complexes of 99m Tc and their use for myocardial and hepatobiliary imaging
Sadeghzadeh et al. Synthesis, radiolabeling and biological evaluation of 99mTc-labeled deoxyglucose derivatives for molecular imaging
US4515766A (en) Labeled phosphonic acid compositions for investigations of in vivo deposits of calcium
KR100430061B1 (ko) 글루코스 유도체에 방사성 동위원소가 표지된 착화합물 및이를 생산하기 위한 조성물이 포함된 키트
WO1991017168A1 (en) Gallium-labelled imaging agents
EP0201005A2 (en) 99mTc(III)myocardial imaging agents which are non-reducable in vivo
Zhang et al. Preparation, characterization and biodistribution of a new technetium‐99 m nitrido complex with 2‐methoxyisobutylisonitrile and comparison with 99mTc–MIBI
US4617184A (en) 99m Tc-1,2-dihydroxy-1,2-bis(dihydroxyphosphinyl)ethane complex for skeleton scanning
Kothari et al. Synthesis of 99mTc (CO) 3‐mebrofenin via [99mTc (OH2) 3 (CO) 3]+ precursor and comparative pharmacokinetics studies with 99mTc‐mebrofenin
Zhang et al. Synthesis and biodistribution of 99mTcN (PDTC) 2as a potential brain imaging agent
CN120230182B (zh) 经修饰的caix靶向环肽及其核素标记物与应用
Vora et al. In vivo studies of unlabeled and radioiodinated rhodamine-123
Woo Radio-labelled quaternary compounds and their diagnostic use
Zhang et al. Synthesis and biodistribution in mice of a new 99mTc nitrido complex for brain imaging
Takeda et al. Chemical properties of technetium-99m-DL-homocysteine, a possible tumor-imaging agent
Kelly Choice of radionuclides for scintigraphy

Legal Events

Date Code Title Description
MKEX Expiry